Scinai Immunotherapeutics...

NASDAQ: SCNI · Real-Time Price · USD
1.54
0.01 (0.65%)
At close: Aug 20, 2025, 3:59 PM
1.66
7.73%
After-hours: Aug 20, 2025, 07:59 PM EDT

Scinai Immunotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-6.5M -5.8M -8.21M
Depreciation & Amortization
514K 562K 471K
Stock-Based Compensation
1.14M 1.6M 2.76M
Other Working Capital
-356K 306K 650.85K
Other Non-Cash Items
-3.89M -4.08M -3.15M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-646K 446K 701K
Operating Cash Flow
-9.38M -7.26M -7.43M
Capital Expenditures
-637K -836K -133.12K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-637K -836K -139K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
947K 6.78M 21.43M
Financial Cash Flow
1.09M 6.78M 21.43M
Net Cash Flow
-9.21M -3.3M 14.59M
Free Cash Flow
-10.02M -8.1M -7.57M